Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

NCT02291237 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG: Eleclazine
DRUG: Placebo

Sponsor

Gilead Sciences